MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2023 International Congress

    Preoperative motor deficits and depressive symptoms predict quality of life in patients with Parkinson’s disease at different time points after surgery for subthalamic stimulation.

    C. Semmler (Cologne, Germany)

    Objective: This retrospective study explored whether preoperative motor, cognitive, and affective parameters predict QoL and QoL components at 6 and 12 months after STN-DBS surgery.…
  • 2023 International Congress

    Comparison of biospecimens for α-synuclein seed amplification assays in Parkinson’s disease: A Systematic Review and Network Meta-Analysis

    SM. Li, YC. Zheng, C. Yang, ZW. Yu, Y. Jiang, T. Feng (Beijing, China)

    Objective: We performed meta-analysis to determine the diagnostic and differential diagnostic value of α-syn SAAs for PD, and to investigate the optimal specimens. Background: Alpha-synuclein…
  • 2023 International Congress

    Parkinson’s Disease and Chronic Inflammatory Demyelinating Polyneuropathy: Broadening the Clinical Spectrum of VCP Mutations?

    E. Contaldi, L. Magistrelli, R. Cantello, S. Gallo, F. Vignaroli (Novara, Italy)

    Objective: Valosin-containing protein (VCP) mutation causes a multiorgan disease characterized by inclusion body myopathy, Paget disease and frontotemporal dementia, more rarely by Charcot-Marie-Tooth disease type…
  • 2023 International Congress

    Bridging the Gap between Statistical significance and Clinical Relevance: A Systematic Review of Minimum clinically important difference (MCID) thresholds of scales reported in trials of Movement Disorders

    B. Mishra, S. Pachipala, R. Rajan, A. Agarwal, MVP. Srivastava, N. Nilima, VY. Vishnu (Delhi, India)

    Objective: To provide a comprehensive review of various patient-reported outcome (PROs) used in movement disorders (MD) research and their MCID values reported in literature. Background:…
  • 2023 International Congress

    Clinico-pathological correlations in atypical parkinsonism

    R. Fumi, M. Theilmann Jensen, L. Wu, D. Vaughan, V. Chelban, Y. Goh, R. Real, A. Martinez Carrasco, E. Jabbari, A. Church, J. Coebergh, C. Kobylecki, U. Nath, M. Hu, A. Misbahuddin, J. Sharma, L. Massey, E. Capps, A. Robinson, F. Roncaroli, A. Lees, O. Ansorge, K. Allison, T. Warner, J. Rohrer, T. Revesz, Z. Jaunmuktane, J. Rowe, H. Houlden, H. Morris (London, United Kingdom)

    Objective: We aim to assess diagnostic accuracy of the Parkinson-plus syndromes (PPS) using the current consensus criteria, whilst identifying the diagnostically most salient clinical features.…
  • 2023 International Congress

    Characterization of gait variability of early Parkinson’s disease and multiple system atrophy

    M. Jecmenica Lukic, A. Tomic, I. Stankovic, V. Markovic, N. Kresojevic, N. Dragasevic, M. Svetel, I. Petrovic, S. Radovanovic, V. Kostic (Belgrade, Serbia)

    Objective: to determine the potential differences in gait characteristics between PD-GBA carriers and non-carriers (idiopathic Parkinson’s disease (iPD)), both mutually and in relation to MSA-P.…
  • 2023 International Congress

    The phenotypic spectrum and assessment of severity in patients of Spinocerebellar Ataxia-12.

    V. Mathur, A. Shetty, P. Wadia (Jaipur, India)

    Objective: To describe clinical phenotype, manifestations, and assess tremor severity using standard rating scale in genetically confirmed patients with SCA12. Background: Spinocerebellar Ataxia-12 (SCA12) occurs…
  • 2023 International Congress

    Severe parkinsonism late-onset in Wilson’s disease without typical basal ganglia involvement

    J. Li, K-F. Li, J. Ge, H-Z. Chen, W-M. Yang (Hefei, China)

    Objective: Wilson's disease (WD) is an autosomal-recessive copper metabolism disease caused by ATP7B mutations. Background: Here we described an interesting case of WD. Method: A…
  • 2023 International Congress

    Cardiovascular complications in Parkinsonism: insights from Luxembourg Parkinson’s Study

    S. Acharya, A. Lumley, Y. Devaux (Strassen, Luxembourg)

    Objective: Our study aimed at determining the frequency and risk of cardiovascular diseases (CVDs) in Parkinsonian patients in the Luxembourg Parkinson’s Study (LuxPARK). Background: The…
  • 2023 International Congress

    Using Long read sequencing to identify complex structural variants in PRKN-PD

    K. Daida, M. Funayama, A. Miano-Burkhardt, L. Mailik, K. Billingsley, M. Ishiguro, H. Yoshino, K. Ogaki, G. Oyama, R. Nonaka, W. Akamatsu, C. Blauwendraat, N. Hattori (Bethesda, USA)

    Objective: Identify complex structural variants in PRKN gene from Parkinson’s disease patients. Background: PRKN is the most frequent causative gene in young onset Parkinson's disease…
  • « Previous Page
  • 1
  • …
  • 21
  • 22
  • 23
  • 24
  • 25
  • …
  • 388
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley